NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered peptides from Orbitrex Peptides? Mail in a sample (US only) and let us test it.

Test my supply
71%
Finnrick rating
#272 of 457 ranked vendors
37 of 43 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Orbitrex Peptides shows its strongest purity-focus evidence in GHK-Cu and later Retatrutide, with identity passes, high purities, and fills generally inside this method's tolerance. Tirzepatide and early Retatrutide are weaker, and the evidence is uneven: Retatrutide has most volume, while GHK-Cu is thinner and batch-source gaps limit traceability.

methodology →
vendor intelligence report
Vendor Intelligence Report: Orbitrex Peptides

We investigated who actually operates Orbitrex Peptides — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.

21 pages6 risk factors assessed13 Jun 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Retatrutide
$6.40
91%
24
2
GHK-Cu
$0.80
90%
7
3
Tirzepatide
$5.00
78%
5
4
PT-141
-
69%
2
5
BPC-157
$4.00
55%
6
6
TB-500
-
33%
2
Contact channels
Vendor policies

Batch identification policy

All product labels include batch ID printed. QR code is fixed on the label to direct to that batch's specific certificate of analysis.

Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%23 Oct 2025: 74%27 Oct 2025: 81%27 Oct 2025: 82%23 Nov 2025: 79%23 Nov 2025: 80%23 Nov 2025: 80%24 Nov 2025: 81%10 Dec 2025: 70%13 Feb 2026: 71%13 Feb 2026: 71%2 Mar 2026: 72%4 Mar 2026: 72%18 Mar 2026: 72%25 Mar 2026: 73%29 Mar 2026: 73%23 Apr 2026: 73%23 Apr 2026: 73%28 Apr 2026: 74%28 Apr 2026: 74%28 May 2026: 74%2 Jun 2026: 74%2 Jun 2026: 74%12 Jun 2026: 75%17 Jul 2026: 73%17 Jul 2026: 74%23 Jul 2026: 76%23 Jul 2026: 77%2 Aug 2026: 77%8 Sep 2026: 77%9 Sep 2026: 77%9 Sep 2026: 77%15 Sep 2026: 77%15 Sep 2026: 77%16 Sep 2026: 78%24 Sep 2026: 71%24 Sep 2026: 71%24 Sep 2026: 71%24 Sep 2026: 71%24 Sep 2026: 71%24 Sep 2026: 71%7 Oct 2026: current 71%74%72%71%Oct 25Oct 26
Free peptide testing

Ordered peptides from Orbitrex Peptides? Mail in a sample (US only) and let us test it.

Test my supply
Orbitrex Peptides test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
24 Sep 2026
Pass
Retatrutide
lab nameView COA
24 Sep 2026
Fail
TB-500 (Thymosin Beta-4)
lab nameView COA
24 Sep 2026
Fail
BPC-157
lab nameView COA
24 Sep 2026
Fail
TB-500 (Thymosin Beta-4)
lab nameView COA
24 Sep 2026
Pass
Retatrutide
lab nameView COA
24 Sep 2026
Pass
BPC-157
lab nameView COA
16 Sep 2026
Pass
Retatrutide
lab nameView COA
15 Sep 2026
Pass
BPC-157
lab nameView COA
15 Sep 2026
Pass
GHK-Cu
lab nameView COA
9 Sep 2026
Pass
Retatrutide
lab nameView COA
1-10 of 46

About Orbitrex Peptides test results from Finnrick

Orbitrex Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 46 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Orbitrex Peptides peptides in this dataset are Retatrutide (24 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 46 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered peptides from Orbitrex Peptides? Mail in a sample (US only) and let us test it.

Test my supply